Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study

Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study

Abstract Objective Need for rescue therapy differs among patients with seizure clusters. Diazepam nasal spray is approved to treat seizure clusters in patients with epilepsy ≥6 years of age. This analysis used interim data from a phase 3 safety study to assess safety profile and effectiveness of dia...

Full description

Bibliographic Details
Main Authors: Ian Miller, James W. Wheless, Robert E. Hogan, Dennis Dlugos, Victor Biton, Gregory D. Cascino, Michael R. Sperling, Kore Liow, Blanca Vazquez, Eric B. Segal, Daniel Tarquinio, Weldon Mauney, Jay Desai, Adrian L. Rabinowicz, Enrique Carrazana, The DIAZ.001.05 Study Group
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Epilepsia Open
Subjects:
acute repetitive seizure
diazepam
dosing frequency
intranasal
nasal spray
seizure cluster
Online Access:https://doi.org/10.1002/epi4.12494

Internet

https://doi.org/10.1002/epi4.12494

Similar Items